Page last updated: 2024-11-05

urapidil and Depressive Disorder, Major

urapidil has been researched along with Depressive Disorder, Major in 1 studies

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research Excerpts

ExcerptRelevanceReference
" We analysed the number of sessions until completion of ECT treatment (used as a surrogate parameter for outcome), psychopathology as assessed by pre- and post-ECT Mini-Mental State Examination (MMSE) and Hamilton Rating Scale for Depression (HAM-D) scores as well as ECT and seizure parameters (stimulation dose, seizure duration and concordance, urapidil dosage for post-seizure blood pressure management)."1.37Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. ( Hoyer, C; Kammerer-Ciernioch, J; Kranaster, L; Sartorius, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kranaster, L1
Kammerer-Ciernioch, J1
Hoyer, C1
Sartorius, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy ---a Randomized Control Double-Blind Clinical Trial[NCT02305394]Phase 4132 participants (Anticipated)Interventional2015-01-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for urapidil and Depressive Disorder, Major

ArticleYear
Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.
    European archives of psychiatry and clinical neuroscience, 2011, Volume: 261, Issue:8

    Topics: Aged; Anesthetics, Dissociative; Anesthetics, Intravenous; Antihypertensive Agents; Cognition Disord

2011